Skip to main content
Premium Trial:

Request an Annual Quote

Toronto Health Clinic to Offer GeneNews' Colorectal Cancer Test

NEW YORK (GenomeWeb News) - Scienta Health, a Toronto-based health clinic, will offer GeneNews’ colorectal cancer risk-assessment test to its patients, GeneNews said today.
 
Scienta will offer ColonSentry to its clients as an “optional component” in their annual health assessments, Toronto-based GeneNews said.
 
Elaine Chin, chief medical officer and co-founder of Scienta Health, said in a statement that ColonSentry “provides a more accurate and reliable basis for recommending colonoscopies than demographic benchmarks or the less sophisticated occult blood stool test.”
 
Heiner Dreismann, interim CEO and lead director of GeneNews, said that the partnership with Scienta is an example of “one component” of the company’s commercialization strategy for ColonSentry. “In the coming months, we expect to roll out our test in additional regions in Canada and target private health insurers to include our test under their healthcare offerings,” he said.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.